Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
about
The challenge of developmental therapeutics for adrenocortical carcinomaA unique co-culture model for fundamental and applied studies of human fetoplacental steroidogenesis and interference by environmental chemicalsSelective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cellsEmerging therapy for adrenocortical carcinoma.Current and emerging therapeutic options in adrenocortical cancer treatment.GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivoEstrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC)Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal womenThe role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience.Dihydrotestosterone stimulates aldosterone secretion by H295R human adrenocortical cells.Expression of estrogen and progesterone receptors across human malignancies: new therapeutic opportunities.Effects of single pesticides and binary pesticide mixtures on estrone production in H295R cells.Expression of oestrogen receptor beta isoforms is regulated by transcriptional and post-transcriptional mechanisms.Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway.Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.
P2860
Q28072970-13BF618F-D837-4BAB-B466-2FBBBF2CD037Q28383904-EEACEA90-6606-46B4-829D-B01804518E00Q28567192-F179EC9B-72AE-4FA6-A132-33B486CA1016Q35018399-C2E958FF-167B-4C78-88B1-F7ED70CD3684Q36183873-5C1D0B35-C2F1-4BD4-9569-BD9C8B60637AQ36326358-CE21D379-9598-4FE3-8EC7-C76D14620FBCQ36413130-C77EF63F-E8C8-4786-BF1A-76177AA48A53Q36494366-0C4847C5-8E23-42A8-B561-5CF835F19AA0Q36937823-00555DB5-B953-4A85-AF87-6F8E6D6AD761Q37190418-621F5E4A-42F5-4AF5-B250-D23C2CFA475BQ38301592-C7A694B7-1F5B-464C-9652-16079AD38FECQ39147311-8C9A2C8C-019E-420F-96CD-2D2EA9A0066DQ39704713-06F0419E-01EC-4168-9698-60697EA25185Q47163309-7DD36689-2B5D-481D-83BA-A43BD8DA943FQ49245210-B7F517A6-7A65-40CF-8E03-1F869A765317Q51466111-C5449F93-2D52-470B-B6DB-B67C3CCC3F3D
P2860
Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antiestrogens upregulate estro ...... ical H295R cell proliferation.
@en
type
label
Antiestrogens upregulate estro ...... ical H295R cell proliferation.
@en
prefLabel
Antiestrogens upregulate estro ...... ical H295R cell proliferation.
@en
P2093
P50
P356
P1476
Antiestrogens upregulate estro ...... tical H295R cell proliferation
@en
P2093
P304
P356
10.1677/JME.1.01806
P577
2005-10-01T00:00:00Z